Sagent Pharmaceuticals Inc (NASDAQ:SGNT), saw an insider increase his position with the company. Chief Legal Officer Michael Logerfo acquired 12,759 shares…
Browsing: (NASDAQ:SGNT)
Robert Flanagan, Director at Sagent Pharmaceuticals Inc. (NASDAQ:SGNT), completed a stock disposition of 16,000 shares on Friday. The Common Stock…